Azalia de la Caridad Rodríguez Taño, MSc, has a bachelor’s degree in biochemistry and molecular biology and a master’s degree in biochemistry, both from Havana University. Azalia works as Specialist in the R&D Department Quality Control Group at the Center of Molecular Immunology in Havana, serving as the main analyst of circular dichroism and fluorescence methods in the characterization and comparability study of therapeutic monoclonal antibodies by circular dichroism and fluorescence.
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseasesSparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061 and chronic conditions such as cancer